PubMed

Nucleotide supplementation: a randomised double-blind placebo controlled trial of IntestAidIB in people with Irritable Bowel Syndrome [ISRCTN67764449].

Dancey CP, Attree EA, Brown KF.

Nutr J. 2006 Jun 8;5:16.PMID: 16762076 [PubMed - indexed for MEDLINE]Related articlesFree article

Peppermint oil (Mintoil) in the treatment of irritable bowel syndrome: a prospective double blind placebo-controlled randomized trial.

Cappello G, Spezzaferro M, Grossi L, Manzoli L, Marzio L.

Dig Liver Dis. 2007 Jun;39(6):530-6. Epub 2007 Apr 8.PMID: 17420159 [PubMed - indexed for MEDLINE]Related articles

Tegaserod for the treatment of irritable bowel syndrome and chronic constipation.

Evans BW, Clark WK, Moore DJ, Whorwell PJ.

Cochrane Database Syst Rev. 2007 Oct 17;(4):CD003960. Review.PMID: 17943807 [PubMed - indexed for MEDLINE]Related articles

Symptomatic efficacy of beidellitic montmorillonite in irritable bowel syndrome: a randomized, controlled trial.

Ducrotte P, Dapoigny M, Bonaz B, Siproudhis L.

Aliment Pharmacol Ther. 2005 Feb 15;21(4):435-44.PMID: 15709995 [PubMed - indexed for MEDLINE]Related articlesFree article

A randomised controlled trial assessing the efficacy and safety of repeated tegaserod therapy in women with irritable bowel syndrome with constipation.

Tack J, Müller-Lissner S, Bytzer P, Corinaldesi R, Chang L, Viegas A, Schnekenbuehl S, Dunger-Baldauf C, Rueegg P.

Gut. 2005 Dec;54(12):1707-13. Epub 2005 Jul 14.PMID: 16020489 [PubMed - indexed for MEDLINE]Related articlesFree article

Bacterial supplementation in the irritable bowel syndrome. A randomised double-blind placebo-controlled crossover study.

O'Sullivan MA, O'Morain CA.

Dig Liver Dis. 2000 May;32(4):294-301.PMID: 11515626 [PubMed - indexed for MEDLINE]Related articles

Clinical trial: phase 2 study of lubiprostone for irritable bowel syndrome with constipation.

Johanson JF, Drossman DA, Panas R, Wahle A, Ueno R.

Aliment Pharmacol Ther. 2008 Apr;27(8):685-96. Epub 2008 Jan 28.PMID: 18248656 [PubMed - indexed for MEDLINE]Related articles

[A randomized, double-blind, placebo-controlled, multicenter study to assess the efficacy and safety of tegaserod in Chinese patients with constipation-predominant irritable bowel syndrome]

Tegaserod Clinical Research Group.

Zhonghua Nei Ke Za Zhi. 2003 Feb;42(2):88-90. Chinese. PMID: 12783702 [PubMed - indexed for MEDLINE]Related articles

A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome.

Drouault-Holowacz S, Bieuvelet S, Burckel A, Cazaubiel M, Dray X, Marteau P.

Gastroenterol Clin Biol. 2008 Feb;32(2):147-52. Epub 2008 Mar 4.PMID: 18387426 [PubMed - indexed for MEDLINE]Related articlesFree article

The effect of fluoxetine in patients with pain and constipation-predominant irritable bowel syndrome: a double-blind randomized-controlled study.

Vahedi H, Merat S, Rashidioon A, Ghoddoosi A, Malekzadeh R.

Aliment Pharmacol Ther. 2005 Sep 1;22(5):381-5.PMID: 16128675 [PubMed - indexed for MEDLINE]Related articlesFree article

Daily stress and gastrointestinal symptoms in women with irritable bowel syndrome.

Hertig VL, Cain KC, Jarrett ME, Burr RL, Heitkemper MM.

Nurs Res. 2007 Nov-Dec;56(6):399-406.PMID: 18004186 [PubMed - indexed for MEDLINE]Related articles

A randomized controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating.

Kim HJ, Vazquez Roque MI, Camilleri M, Stephens D, Burton DD, Baxter K, Thomforde G, Zinsmeister AR.

Neurogastroenterol Motil. 2005 Oct;17(5):687-96.PMID: 16185307 [PubMed - indexed for MEDLINE]Related articles

A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome.

Kim HJ, Camilleri M, McKinzie S, Lempke MB, Burton DD, Thomforde GM, Zinsmeister AR.

Aliment Pharmacol Ther. 2003 Apr 1;17(7):895-904.PMID: 12656692 [PubMed - indexed for MEDLINE]Related articlesFree article

Clinical trial: renzapride therapy for constipation-predominant irritable bowel syndrome--multicentre, randomized, placebo-controlled, double-blind study in primary healthcare setting.

George AM, Meyers NL, Hickling RI.

Aliment Pharmacol Ther. 2008 May;27(9):830-7. Epub 2008 Feb 14.PMID: 18284648 [PubMed - indexed for MEDLINE]Related articles

Melatonin improves abdominal pain in irritable bowel syndrome patients who have sleep disturbances: a randomised, double blind, placebo controlled study.

Song GH, Leng PH, Gwee KA, Moochhala SM, Ho KY.

Gut. 2005 Oct;54(10):1402-7. Epub 2005 May 24.PMID: 15914575 [PubMed - indexed for MEDLINE]Related articlesFree article

Improvement in pain and bowel function in female irritable bowel patients with alosetron, a 5-HT3 receptor antagonist.

Camilleri M, Mayer EA, Drossman DA, Heath A, Dukes GE, McSorley D, Kong S, Mangel AW, Northcutt AR.

Aliment Pharmacol Ther. 1999 Sep;13(9):1149-59.PMID: 10468696 [PubMed - indexed for MEDLINE]Related articlesFree article

Soluble or insoluble fibre in irritable bowel syndrome in primary care? Randomised placebo controlled trial.

Bijkerk CJ, de Wit NJ, Muris JW, Whorwell PJ, Knottnerus JA, Hoes AW.

BMJ. 2009 Aug 27;339:b3154. doi: 10.1136/bmj.b3154.PMID: 19713235 [PubMed - indexed for MEDLINE]Related articlesFree article

Efficacy of dioctahedral smectite in treating patients of diarrhea-predominant irritable bowel syndrome.

Chang FY, Lu CL, Chen CY, Luo JC.

J Gastroenterol Hepatol. 2007 Dec;22(12):2266-72. Epub 2007 Jun 7.PMID: 17559369 [PubMed - indexed for MEDLINE]Related articles

A dose-ranging, phase II study of the efficacy and safety of alosetron in men with diarrhea-predominant IBS.

Chang L, Ameen VZ, Dukes GE, McSorley DJ, Carter EG, Mayer EA.

Am J Gastroenterol. 2005 Jan;100(1):115-23.PMID: 15654790 [PubMed - indexed for MEDLINE]Related articles

Irritable bowel syndrome: more than abdominal pain and bowel habit abnormalities.

Bond B, Quinlan J, Dukes GE, Mearin F, Clouse RE, Alpers DH.

Clin Gastroenterol Hepatol. 2009 Jan;7(1):73-9. Epub 2008 Aug 19.PMID: 19124114 [PubMed - indexed for MEDLINE]Related articles